دورية أكاديمية
أعرض في EDS

The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients.

التفاصيل البيبلوغرافية
العنوان: The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients.
المؤلفون: Weber CK; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Miglioranza MH; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Moraes MA; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Sant'anna RT; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Rover MM; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Kalil RA; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil., Leiria TL; Instituto de Cardiologia, Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil.
المصدر: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2014; Vol. 69 (5), pp. 341-6.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101244734 Publication Model: Print Cited Medium: Internet ISSN: 1980-5322 (Electronic) Linking ISSN: 18075932 NLM ISO Abbreviation: Clinics (Sao Paulo) Subsets: MEDLINE
أسماء مطبوعة: Publication: 2022- : [New York] : Elsevier
Original Publication: São Paulo, SP : Hospital das Clínicas, Faculty of Medicine, University of São Paulo, [2005]-
مواضيع طبية MeSH: Dyspnea/*physiopathology , Heart Failure/*physiopathology , Psychometrics/*instrumentation , Pulmonary Edema/*diagnosis, Adult ; Brazil ; Cohort Studies ; Dyspnea/etiology ; Female ; Follow-Up Studies ; Heart Failure/complications ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain/analysis ; Outpatients ; Peptide Fragments/analysis ; Prognosis ; Prospective Studies ; Pulmonary Edema/complications ; Pulmonary Edema/diagnostic imaging ; Ultrasonography ; Ventricular Function, Left/physiology
مستخلص: Objectives: Proper assessment of dyspnea is important in patients with heart failure. Our aim was to evaluate the use of the 5-point Likert scale for dyspnea to assess the degree of pulmonary congestion and to determine the prognostic value of this scale for predicting adverse events in heart failure outpatients.
Methods: We undertook a prospective study of outpatients with moderate to severe heart failure. The 5-point Likert scale was applied during regular outpatient visits, along with clinical assessments. Lung ultrasound with ≥15 B-lines and an amino-terminal portion of pro-B-type natriuretic peptide (NT-proBNP) level >1000 pg/mL were used as a reference for pulmonary congestion. The patients were then assessed every 30 days during follow-up to identify adverse clinical outcomes.
Results: We included 58 patients (65.5% male, age 43.5 ± 11 years) with a mean left ventricular ejection fraction of 27 ± 6%. In total, 29.3% of these patients had heart failure with ischemic etiology. Additionally, pulmonary congestion, as diagnosed by lung ultrasound, was present in 58% of patients. A higher degree of dyspnea (3 or 4 points on the 5-point Likert scale) was significantly correlated with a higher number of B-lines (p = 0.016). Patients stratified into Likert = 3-4 were at increased risk of admission compared with those in class 1-2 after adjusting for age, left ventricular ejection fraction, New York Heart Association functional class and levels of NT-proBNP >1000 pg/mL (HR = 4.9, 95% CI 1.33-18.64, p = 0.017).
Conclusion: In our series, higher baseline scores on the 5-point Likert scale were related to pulmonary congestion and were independently associated with adverse events during follow-up. This simple clinical tool can help to identify patients who are more likely to decompensate and whose treatment should be intensified.
References: Intensive Care Med. 2012 Apr;38(4):577-91. (PMID: 22392031)
Curr Heart Fail Rep. 2009 Jun;6(2):95-101. (PMID: 19486593)
Am J Med. 2006 Dec;119(12 Suppl 1):S3-S10. (PMID: 17113398)
Eur Heart J. 2010 Apr;31(7):832-41. (PMID: 19906690)
Circulation. 2002 Jul 23;106(4):416-22. (PMID: 12135939)
Circ Heart Fail. 2013 May;6(3):461-72. (PMID: 23584092)
J Am Coll Cardiol. 2008 Sep 16;52(12):997-1003. (PMID: 18786480)
Eur Heart J. 2010 Apr;31(7):771-2. (PMID: 20167742)
Am Heart J. 2003 Feb;145(2 Suppl):S26-33. (PMID: 12594449)
JACC Cardiovasc Imaging. 2013 Nov;6(11):1141-51. (PMID: 24094830)
Am J Med. 1991 Mar;90(3):353-9. (PMID: 1825901)
Heart Fail Rev. 2010 Jan;15(1):63-72. (PMID: 19504345)
Eur J Heart Fail. 2008 Jan;10(1):70-7. (PMID: 18077210)
West J Emerg Med. 2011 Feb;12(1):102-6. (PMID: 21691481)
Ther Umsch. 2009 Sep;66(9):639-42. (PMID: 19725007)
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. (PMID: 22336677)
Congest Heart Fail. 2010 Mar-Apr;16(2):60-4. (PMID: 20412470)
Eur Heart J. 2008 Mar;29(6):816-24. (PMID: 18310669)
Prog Cardiovasc Dis. 2002 Jan-Feb;44(4):293-321. (PMID: 12007084)
Congest Heart Fail. 2010 Sep-Oct;16(5):202-7. (PMID: 20887616)
Eur Heart J. 2012 Jul;33(14):1787-847. (PMID: 22611136)
Pacing Clin Electrophysiol. 2011 Aug;34(8):968-74. (PMID: 21477028)
N Engl J Med. 1971 Dec 23;285(26):1441-6. (PMID: 5122894)
المشرفين على المادة: 0 (Peptide Fragments)
0 (pro-brain natriuretic peptide (1-76))
114471-18-0 (Natriuretic Peptide, Brain)
تواريخ الأحداث: Date Created: 20140520 Date Completed: 20141215 Latest Revision: 20220629
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4012234
DOI: 10.6061/clinics/2014(05)08
PMID: 24838900
قاعدة البيانات: MEDLINE
الوصف
تدمد:1980-5322
DOI:10.6061/clinics/2014(05)08